654 related articles for article (PubMed ID: 33238112)
1. Endosomal Dysfunction Induced by Directly Overactivating Rab5 Recapitulates Prodromal and Neurodegenerative Features of Alzheimer's Disease.
Pensalfini A; Kim S; Subbanna S; Bleiwas C; Goulbourne CN; Stavrides PH; Jiang Y; Lee JH; Darji S; Pawlik M; Huo C; Peddy J; Berg MJ; Smiley JF; Basavarajappa BS; Nixon RA
Cell Rep; 2020 Nov; 33(8):108420. PubMed ID: 33238112
[TBL] [Abstract][Full Text] [Related]
2. Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease.
Kim S; Sato Y; Mohan PS; Peterhoff C; Pensalfini A; Rigoglioso A; Jiang Y; Nixon RA
Mol Psychiatry; 2016 May; 21(5):707-16. PubMed ID: 26194181
[TBL] [Abstract][Full Text] [Related]
3. Rab5-stimulated up-regulation of the endocytic pathway increases intracellular beta-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Abeta production.
Grbovic OM; Mathews PM; Jiang Y; Schmidt SD; Dinakar R; Summers-Terio NB; Ceresa BP; Nixon RA; Cataldo AM
J Biol Chem; 2003 Aug; 278(33):31261-8. PubMed ID: 12761223
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease.
Shen R; Zhao X; He L; Ding Y; Xu W; Lin S; Fang S; Yang W; Sung K; Spencer B; Rissman RA; Lei M; Ding J; Wu C
Transl Neurodegener; 2020 Jun; 9(1):26. PubMed ID: 32552912
[TBL] [Abstract][Full Text] [Related]
5. Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration.
Xu W; Weissmiller AM; White JA; Fang F; Wang X; Wu Y; Pearn ML; Zhao X; Sawa M; Chen S; Gunawardena S; Ding J; Mobley WC; Wu C
J Clin Invest; 2016 May; 126(5):1815-33. PubMed ID: 27064279
[TBL] [Abstract][Full Text] [Related]
6. Assessing Rab5 Activation in Health and Disease.
Pensalfini A; Jiang Y; Kim S; Nixon RA
Methods Mol Biol; 2021; 2293():273-294. PubMed ID: 34453725
[TBL] [Abstract][Full Text] [Related]
7. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model.
Chen XQ; Salehi A; Pearn ML; Overk C; Nguyen PD; Kleschevnikov AM; Maccecchini M; Mobley WC
Alzheimers Dement; 2021 Feb; 17(2):271-292. PubMed ID: 32975365
[TBL] [Abstract][Full Text] [Related]
8. App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.
Cataldo AM; Petanceska S; Peterhoff CM; Terio NB; Epstein CJ; Villar A; Carlson EJ; Staufenbiel M; Nixon RA
J Neurosci; 2003 Jul; 23(17):6788-92. PubMed ID: 12890772
[TBL] [Abstract][Full Text] [Related]
9. A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ.
Kwart D; Gregg A; Scheckel C; Murphy EA; Paquet D; Duffield M; Fak J; Olsen O; Darnell RB; Tessier-Lavigne M
Neuron; 2019 Oct; 104(2):256-270.e5. PubMed ID: 31416668
[TBL] [Abstract][Full Text] [Related]
10. Ulk1 Governs Nerve Growth Factor/TrkA Signaling by Mediating Rab5 GTPase Activation in Porcine Hemagglutinating Encephalomyelitis Virus-Induced Neurodegenerative Disorders.
Li Z; Zhao K; Lv X; Lan Y; Hu S; Shi J; Guan J; Yang Y; Lu H; He H; Gao F; He W
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875237
[TBL] [Abstract][Full Text] [Related]
11. Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression.
Ginsberg SD; Alldred MJ; Counts SE; Cataldo AM; Neve RL; Jiang Y; Wuu J; Chao MV; Mufson EJ; Nixon RA; Che S
Biol Psychiatry; 2010 Nov; 68(10):885-93. PubMed ID: 20655510
[TBL] [Abstract][Full Text] [Related]
12. Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease.
Nixon RA
FASEB J; 2017 Jul; 31(7):2729-2743. PubMed ID: 28663518
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99).
Jiang Y; Sato Y; Im E; Berg M; Bordi M; Darji S; Kumar A; Mohan PS; Bandyopadhyay U; Diaz A; Cuervo AM; Nixon RA
J Neurosci; 2019 Jul; 39(27):5255-5268. PubMed ID: 31043483
[TBL] [Abstract][Full Text] [Related]
14. Rab5 mediates an amyloid precursor protein signaling pathway that leads to apoptosis.
Laifenfeld D; Patzek LJ; McPhie DL; Chen Y; Levites Y; Cataldo AM; Neve RL
J Neurosci; 2007 Jul; 27(27):7141-53. PubMed ID: 17611268
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of Rab5-mediated endocytic pathways in Alzheimer's disease.
Xu W; Fang F; Ding J; Wu C
Traffic; 2018 Apr; 19(4):253-262. PubMed ID: 29314494
[TBL] [Abstract][Full Text] [Related]
16. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
[TBL] [Abstract][Full Text] [Related]
17. Exploring the potential role of rab5 protein in endo-lysosomal impairment in Alzheimer's disease.
Behl T; Kaur D; Sehgal A; Singh S; Makeen HA; Albratty M; Abdellatif AAH; Dachani SR; Bungau S
Biomed Pharmacother; 2022 Apr; 148():112773. PubMed ID: 35245734
[TBL] [Abstract][Full Text] [Related]
18. Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects.
Cataldo AM; Mathews PM; Boiteau AB; Hassinger LC; Peterhoff CM; Jiang Y; Mullaney K; Neve RL; Gruenberg J; Nixon RA
Am J Pathol; 2008 Aug; 173(2):370-84. PubMed ID: 18535180
[TBL] [Abstract][Full Text] [Related]
19. cGMP favors the interaction between APP and BACE1 by inhibiting Rab5 GTPase activity.
Caudano F; Montalto G; Passalacqua M; Pronzato MA; Fedele E; Ricciarelli R
Sci Rep; 2020 Jan; 10(1):1358. PubMed ID: 31992816
[TBL] [Abstract][Full Text] [Related]
20. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis.
Cataldo AM; Barnett JL; Pieroni C; Nixon RA
J Neurosci; 1997 Aug; 17(16):6142-51. PubMed ID: 9236226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
